Regulation
FDA clears Myrava’s patient-specific bolus device
Myrava received 510(k) clearance from the FDA for its patient-specific, 3D-printed bolus device designed for use in radiation therapy. The device is manufactured using 3D printing technology to customize bolus shapes for individual patients during treatment.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network